Who owns TENAX THERAPEUTICS INC?
- Ticker: TENX
- CUSIP Number: 88032l605
Tip: Access positions for across all investors
Analyze quarterly positions in Tenax Therapeutics with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Tenax Therapeutics stock
Who bought or sold TENAX THERAPEUTICS INC this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| Henderson Group | 1.8M | $29M | 989% | Mar 2026 |
|
| VR Adviser | 1.7M | $27M | 100% | Mar 2026 |
|
| Perceptive Advisors | 1.4M | $23M | 230% | Mar 2026 |
|
| Ikarian Capital | 1.1M | $18M | 17% | Mar 2026 |
|
| Logos Global Management | 625k | $10M | 100% | Mar 2026 |
|
| Morgan Stanley | 597k | $9.5M | 0% | Mar 2026 |
|
| Point72 Asset Management | 534k | $8.5M | 26% | Mar 2026 |
|
| Millennium Management | 534k | $8.5M | 77% | Mar 2026 |
|
| Armistice Capital | 479k | $7.7M | 100% | Mar 2026 |
|
| Siren | 427k | $5.2M | 21% | Dec 2025 |
|
| Boothbay Fund Management | 400k | $6.4M | 14% | Mar 2026 |
|
| TD Asset Management | 399k | $6.4M | 100% | Mar 2026 |
|
| UBS Group | 381k | $6.1M | 56323% | Mar 2026 |
|
| Rtw Investments | 378k | $4.6M | 0% | Dec 2025 |
|
| BVF | 340k | $5.4M | 0% | Mar 2026 |
|
| Dr. Jeffrey R. Jay, M.D. | 327k | $5.2M | 100% | Mar 2026 |
|
| Woodline Partners | 324k | $5.2M | 126% | Mar 2026 |
|
| Marshall Wace | 298k | $3.6M | 68% | Dec 2025 |
|
| Ameriprise Financial | 280k | $4.5M | 100% | Mar 2026 |
|
| Avidity Partners Management | 216k | $3.5M | 100% | Mar 2026 |
|
| Vanguard Capital Management | 263k | $4.2M | 100% | Mar 2026 |
|
| Vanguard Group | 256k | $3.1M | 58% | Dec 2025 |
|
| Diadema Partners | 243k | $3.0M | 100% | Dec 2025 |
|
| ADAR1 Capital Management | 214k | $3.4M | 235% | Mar 2026 |
|
| Vivo Capital | 208k | $3.3M | 0% | Mar 2026 |
|
| Boone Capital Management | 200k | $3.2M | 100% | Mar 2026 |
|
| Balyasny Asset Management | 195k | $3.1M | 100% | Mar 2026 |
|
| Stempoint Capital | 189k | $3.0M | 100% | Mar 2026 |
|
| Integral Health Asset Management | 167k | $2.0M | 0% | Dec 2025 |
|
| Citadel Advisors | 153k | $2.4M | 18% | Mar 2026 |
|
| FMR | 141k | $1.7M | 100% | Dec 2025 |
|
| Sphera Funds Management | 136k | $2.2M | -28% | Mar 2026 |
|
| Renaissance Technologies | 126k | $1.5M | 122% | Dec 2025 |
|
| Sofinnova Ventures | 104k | $1.7M | 100% | Mar 2026 |
|
| Velan Capital Investment Management | 83k | $1.0M | 0% | Dec 2025 |
|
| Adage Capital Partners GP | 83k | $1.0M | 0% | Dec 2025 |
|
| Geode Capital Management | 69k | $1.1M | 24% | Mar 2026 |
|
| Two Sigma Investments | 69k | $1.1M | 105% | Mar 2026 |
|
| Dimensional Fund Advisors | 63k | $1.0M | 100% | Mar 2026 |
|
| Persistent Asset Partners | 58k | $930k | -11% | Mar 2026 |
|
| Vestal Point Capital | 53k | $855k | 0% | Mar 2026 |
|
| Trexquant Investment | 51k | $811k | 100% | Mar 2026 |
|
| Creek Drive Management Group | 45k | $720k | 100% | Mar 2026 |
|
| Bridgeway Capital Management | 45k | $547k | 100% | Dec 2025 |
|
| Artia Global Partners | 42k | $673k | 0% | Mar 2026 |
|
| Hrt Financial | 42k | $668k | 100% | Mar 2026 |
|
| Jane Street | 34k | $538k | 100% | Mar 2026 |
|
| Vanguard Fiduciary Trust | 33k | $535k | 100% | Mar 2026 |
|
| Goldman Sachs Group | 32k | $509k | 42% | Mar 2026 |
|
| Manufacturers Life Insurance Company | 31k | $501k | 100% | Mar 2026 |
|
| Bnp Paribas Arbitrage, Snc | 31k | $490k | 100% | Mar 2026 |
|
| Quadrature Capital | 21k | $252k | 100% | Dec 2025 |
|
| Bank of America Corporation | 19k | $297k | 100% | Mar 2026 |
|
| BlackRock | 17k | $272k | 2% | Mar 2026 |
|
| CI Private Wealth | 12k | $198k | 0% | Mar 2026 |
|
| Stonepine Capital Management | 12k | $145k | 100% | Dec 2025 |
|
| Letko, Brosseau & Associates | 11k | $170k | 0% | Mar 2026 |
|
| Acadian Asset Management | 4.5k | $71k | 100% | Mar 2026 |
|
| Vanguard Global Advisers | 3.3k | $53k | 100% | Mar 2026 |
|
| Rockefeller Capital Management | 2.5k | $40k | 250000% | Mar 2026 |
|
| Tower Research Capital | 199.00 | $2.4k | -60% | Dec 2025 |
|
| Caitong International Asset Management | 57.00 | $911.002500 | 100% | Mar 2026 |
|
| Royal Bank of Canada | 4.00 | $0 | 100% | Mar 2026 |
|
| Union Bancaire Privee, UBP SA | 1.00 | $11.000000 | 0% | Mar 2026 |
|
| UMA Financial Services | 1.00 | $16.000000 | 0% | Mar 2026 |
|
| Titiun Yejiel | 1.00 | $16.000000 | 0% | Mar 2026 |
|
| Citigroup | 1.00 | $16.000000 | 100% | Mar 2026 |
|
| MAI Wealth Advisors | 1.00 | $16.000000 | 100% | Mar 2026 |
|
| Hanson McClain Advisors | 1.00 | $13.000000 | 0% | Dec 2025 |
|
| Jones Financial Companies, L.L | 1.00 | $12.000000 | 0% | Dec 2025 |
|
Who sold out of Tenax Therapeutics?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| Two Sigma Advisers | Dec 2025 | 13k | $161k |
| Virtu Financial | Sep 2025 | 12k | $92k |